Sponsor

Probelte Pharma S.L.

Spain Calle Antonio Belmonte Abellan 7, 30100 Murcia, Spain

About the sponsor

Probelte Pharma S.L. focuses on allergen immunotherapy for allergic rhinoconjunctivitis, with research centered on grass pollen and house dust mite sensitisation. Its clinical programme includes subcutaneous immunotherapy approaches for patients with respiratory allergy symptoms linked to environmental allergens.

Grass pollen allergy
House dust mite allergy
Allergic rhinoconjunctivitis

The sponsor’s trials also address patients with allergic rhinoconjunctivitis associated with asthma, reflecting interest in upper and lower airway allergic disease.

About Specializations

Probelte Pharma S.L. runs clinical trials in conditions such as Mite allergy, Seasonal allergy, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Quick filters

5 clinical trials

Mite allergy

Recruiting

Investigational

Study on the Effectiveness and Safety of Beltavac for Patients with Allergic Rhinitis from House Dust Mites

Investigational

Spain

Participants:0–17 years · 18–64 years
Substances:Mixture Of Allergen Extracts Of Dermatophagoides Pteronyssinus And Dermatophagoides Farinae Polymerized With Glutaraldehyde
Sponsor:Probelte Pharma S.L.